HIV Viral Load Scale-up Among Children and Adolescents: Trends in Viral Load Suppression, Sample Type and Processing in 7 PEPFAR Countries, 2015-2018.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
01 04 2023
Historique:
pubmed: 3 2 2023
medline: 14 3 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

HIV-positive children and adolescents face gaps in viral load (VL) testing. To understand trends in pediatric/adolescent VL testing, 7 countries collected data from Laboratory Information Management Systems. Results showed increasing proportion of VL tests done through dried blood spot (DBS) and decreased sample rejection rates for DBS compared with plasma, supporting use of DBS VL when skilled phlebotomy is unavailable.

Identifiants

pubmed: 36728122
doi: 10.1097/INF.0000000000003824
pii: 00006454-202304000-00007
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e102-e104

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

AIDSinfo. UNAIDS 2022 estimates. Available at: aidsinfo.unaids.org . Accessed August 23, 2022.
Lecher SL, Fonjungo P, Ellenberger E, et al. HIV viral load monitoring among patients receiving antiretroviral therapy— eight sub-Saharan Africa countries, 2013-2018. MMWR Morb Mortal Wkly Rep. 2021;70:775–778.
US Presidents Emergency Plan for AIDS Relief (PEPFAR) 2022 Country and Regional Operational Plan (COP/ROP) guidance for all PEPFAR countries. Available at: https://www.state.gov/2022-country-operational-plan-guidance . Accessed July 7, 2022.
Bacha JM, Dlamini S, Anawabi F, et al. Achieving antiretroviral therapy uptake and viral suppression among children and adolescents living with HIV in the UNAIDS 90-90-90 era across six countries in Eastern and Southern Africa- lessons from the BIPAI network. JAIDS. 2022;90:300–308.
PEPFAR Panorama Spotlight. US Presidents Emergency Plan for AIDS Relief (PEPFAR). 2021. Available at: https://data.pepfar.gov/additionalData . Accessed October 6, 2021.
Arpadi SM, Shiau S, De Gusmao EP, et al. Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities. J Int AIDS Soc. 2017;20:e25001.
Rutstein S, Golin C, Wheeler SB, et al. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings. AIDS Care. 2016;28:1–10.
World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. 2021. Available at: https://www.who.int/publications/i/item/9789240031593 . Accessed September 14, 2021.
Drain PK, Dorward J, Bender A, et al. Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response. Clin Microbiol Rev. 2019;32:e00097.
Fadare O, Yakubu T, Emerenini F, et al. Sustaining early infant diagnosis of HIV during coronavirus disease 2019 pandemic: experience collecting dried blood spots samples at home from HIV-exposed infants in Nigeria. Pediatric Infect Dis J. 2021;40:e529–e530.

Auteurs

Susan Hrapcak (S)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Sherri Pals (S)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Megumi Itoh (M)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Natalie Peters (N)

Emory University of Medicine, Atlanta, Georgia.

Deborah Carpenter (D)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Stephanie Hackett (S)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Aka K Prao (AK)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Christiane Adje-Toure (C)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Ehui Eboi (E)

HIV/AIDS Program (PNLS), Ministry of Health and Public Hygiene, Côte d'Ivoire, West Africa.

Immaculate Mutisya (I)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Lennah Nyabiage Omoto (L)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Raphael O Ondondo (RO)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Nancy Bowen (N)

Ministry of Health, Nairobi, Kenya.

Winifred Nyanya (W)

Ministry of Health, Nairobi, Kenya.

Dumbani Kayira (D)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Muluken D Kaba (MD)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Rueben Mwenda (R)

Ministry of Health, Lilongwe, Malawi.

Maria Ines Deus (MI)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Jose Almeida (J)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Rosa Marlene M Cuco (RMM)

Ministry of Health (Ministerio da Saude- MISAU), Maputo, Mozambique.

Ashley Boylan (A)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Suzanne Beard (S)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Sylvia Ashikoto (S)

Ministry of Health, Nairobi, Kenya.

Gerhard van Rooyen (G)

Namibia Institute of Pathology, Windhoek, Namibia.

Gurpreet Kindra (G)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Karidia Diallo (K)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Sergio Carmona (S)

Ministry of Health, Johannesburg, South Africa.

Esther Nazziwa (E)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Christina Mwangi (C)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Jonathan Ntale (J)

Division of Global HIV and Tuberculosis, Center for Global Health, CDC.

Isaac Ssewanyana (I)

Ministry of Health, Kampala, Uganda.

Susan N Nabadda (SN)

Ministry of Health, Kampala, Uganda.

Miriam Nabukenya (M)

Ministry of Health, Kampala, Uganda.

Dennis Ellenberger (D)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Emilia Rivadeneira (E)

From the Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention (CDC).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH